- Conditions: Multiple Conditions; Coronary Heart Disease; Diabetes; Hypertension; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: University of Southampton; University of Southampton
Not yet recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/VI; Other: Existing Maintenance Therapy
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium+olodaterol; Drug: tiotropium + olodaterol (high dose); Drug: placebo to tiotropium+olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Acute Leukaemia; Chronic Leukaemia; Myeloma; Lymphoma
Intervention: Radiation: Targeted radiotherapy
Sponsors: Southampton University Hospitals NHS Trust; Southampton University Hospitals NHS Trust; Royal Free and University College Medical School
Recruiting - verified January 2012 - Conditions: Multiple Sclerosis; Fatigue
Interventions: Other: Cognitive behavioural therapy based self help; Other: Treatment as usual
Sponsors: University of Edinburgh; University of Edinburgh
Not yet recruiting - verified January 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Bronchitis, Chronic; Pulmonary Emphysema; Disease Progression
Intervention:
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council; The Hillingdon Hospitals NHS Foundation Trust; West Hertfordshire Hospitals NHS Trust
Recruiting - verified January 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive; Pulmonary Emphysema; Bronchitis, Chronic; Lung Diseases; Disease Progression
Intervention:
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council
Recruiting - verified January 2012 - Conditions: Pain; Hyperalgesia; Chronic Illness; Neuropathic Pain
Interventions: Drug: Pregabalin; Drug: Ketamine infusion; Drug: Placebo capsules; Drug: Placebo infusion
Sponsors: Barts & The London NHS Trust; Barts & The London NHS Trust
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes; Anxiety; Depression
Intervention: Behavioral: CBT-based Guided Self-Help
Sponsors: University of Edinburgh; University of Edinburgh
Not yet recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Glycopyrrolate; Drug: Glycopyrrolate; Drug: Glycopyrrolate; Drug: Comparator
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Placebo; Drug: Formoterol Fumarate
Sponsors: Almirall, S.A.; Almirall, S.A.; Forest Laboratories
Recruiting - verified October 2011 - Conditions: Critical Illness; Intensive Care
Interventions: Other: Exercise Programme; Other: Standard Care
Sponsors: University of Ulster; University of Ulster; Belfast Health and Social Care Trust
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Cachexia; Non-Small Cell Lung Cancer
Interventions: Drug: Anamorelin HCl; Drug: Placebo
Sponsors: Helsinn Therapeutics (U.S.), Inc; Helsinn Therapeutics (U.S.), Inc
Recruiting - verified May 2012 - Condition: Granulomatous Disease, Chronic, X-linked, Variant
Intervention: Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion
Sponsors: Great Ormond Street Hospital for Children NHS Trust; Great Ormond Street Hospital for Children NHS Trust
Not yet recruiting - verified April 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Interventions: Procedure: Blood sample; Procedure: Sputum sample; Procedure: Nasopharyngeal swab; Procedure: Urine sample; Procedure: End tidal breath sample; Other: Data collection; Other: Tests
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Pulmonary Fibrosis
Interventions: Drug: placebo; Drug: BIBF 1120
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: adalimumab; Drug: Placebo; Drug: Placebo; Drug: methotrexate; Drug: folate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Atimos®; Drug: Serevent™; Drug: Placebo
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Recruiting - verified February 2012 - Condition: Myeloid Leukemia, Chronic, Chronic Phase
Interventions: Drug: Imatinib; Drug: Dasatinib
Sponsors: Newcastle University; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust; Bristol-Myers Squibb; Institute of Cancer Research, United Kingdom; Hammersmith Hospitals NHS Trust
Recruiting - verified October 2011 - Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: rituximab [MabThera/Rituxan]; Drug: bendamustine; Drug: chlorambucil
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Castleman's Disease
Interventions: Drug: Placebo; Drug: CNTO 328
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified April 2012 - Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: RO5072759; Drug: rituximab; Drug: chlorambucil
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche; Genentech; German CLL Study Group
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium +salmeterol+ fluticasone high dose; Drug: Tiotropium+salmeterol+ fluticasone high,med, low, placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Chronic Plaque Psoriasis
Intervention: Biological: HUMIRA® (adalimumab)
Sponsors: Abbott; Abbott
Recruiting - verified January 2012 - Condition: Myelogenous Leukemia, Chronic
Interventions: Drug: Nilotinib; Drug: Imatinib
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: the Efficacy and Safety of Off-pump CABG
Interventions: Procedure: Coronary Artery Bypass Graft with the use of CPB; Procedure: Coronary Artery Bypass Graft without the use of CPB
Sponsors: Population Health Research Institute; Population Health Research Institute; McMaster University; University of Oxford; Instituto Dante Pazzanese de Cardiologia; ECLA Clinical Research Organization,; Fu Wai Hospital, Beijing, China; Facultad de Medicina, Universidad de La Frontera, Temuco, Chile; Fundación Cardiovascular de Colombia; Charles University, Czech Republic; Hopital Jean Minjoz; Centre for Chronic Disease Control, India; S. C. di Cardiochirurgia, Ospedale Santa Croce a Carle, Cuneo, Italy; Medical University of Gdansk; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Ankara University; Hotel Dieu Hospital; Centre hospitalier de l'Université de Montréal (CHUM); SAL Hospital, Ahmedabad, India
Recruiting - verified July 2011
 |
Join Clinical Trials for Chronic Illness in the United Kingdom |
